Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion molecule-1

Leslie A Blair1,2, April K Haven1,2, Natalie N Bauer3,4

  • 1Department of Pharmacology, College of Medicine, University of South Alabama, 5851 USA Drive North, MSB 3340, Mobile, AL, 36688, USA.

Respiratory Research
|October 22, 2016
PubMed
Abstract

Insights

In pulmonary arterial hypertension (PAH), late-stage microparticles (MPs) selectively increase ICAM-1 in pulmonary artery cells, not microcirculation. Endoglin-positive MPs drive this response, impacting inflammatory cell recruitment.

Area of Science:

  • Cardiovascular Research
  • Pulmonary Hypertension Pathophysiology
  • Endothelial Cell Biology

Background:

  • Microparticles (MPs) are known to stimulate inflammatory adhesion molecule expression in systemic vascular diseases.
  • The effect of circulating MPs on localized intercellular adhesion molecule 1 (ICAM-1) expression in the distinct pulmonary endothelium during pulmonary arterial hypertension (PAH) remains unclear.
  • Pulmonary vascular lesions in PAH involve inflammatory cell infiltration in arteries and arterioles, but not the microcirculation, suggesting a localized endothelial response.

Purpose of the Study:

  • To investigate whether circulating MPs from a rat model of severe PAH stimulate pulmonary artery endothelial cell-selective ICAM-1 expression.
  • To determine if this ICAM-1 induction is specific to certain segments of the pulmonary circulation.
  • To identify specific MP populations responsible for ICAM-1 stimulation.

Main Methods:

  • Pulmonary artery endothelial cells (PAECs) and pulmonary microvascular endothelial cells (PMVECs) were exposed to MPs isolated from rats with early-stage (3-weeks) and late-stage (8-weeks) PAH.
  • Flow cytometry and cell-based assays were used to measure ICAM-1 expression.
  • Endoglin-positive (endoglin+) MPs were isolated and tested for their ability to induce ICAM-1.

Main Results:

  • Late-stage PAH MPs significantly increased ICAM-1 in PAECs, whereas early-stage PAH MPs did not.
  • Late-stage PAH MPs did not increase ICAM-1 expression in PMVECs, indicating selectivity for the pulmonary artery endothelium.
  • Late-stage endoglin+ PAH MPs were sufficient to promote whole-cell ICAM-1 increases in PAECs, but not surface-only expression.

Conclusions:

  • Circulating MPs from late-stage PAH selectively induce ICAM-1 expression in pulmonary artery endothelium, but not in the pulmonary microcirculation.
  • Endoglin-positive MPs from late-stage PAH are sufficient to drive this selective ICAM-1 response.
  • These findings suggest that MPs play a significant role in inflammatory cell recruitment to vascular lesions in the pulmonary artery during PAH.

Related Concept Videos